GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
Bowel cancer is one of the most common cancers in the UK, with roughly 44,000 new cases each year affecting people of any age ...
A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback